Literature DB >> 22940793

Exposure of population from residential radon: a case study for district Hattian, Azad Kashmir, Sub-Himalayas, Pakistan.

M Rafique1, S U Rahman.   

Abstract

Indoor air quality has acquired considerable importance in recent years. Tighter buildings with poorer ventilation systems have led towards higher levels of indoor air pollution. Radon is considered to be most significant perilous gas among the various air contaminants found in the residential environment. To determine the risk posed by residential radon exposure, a survey was carried out in the Hattian district of the state of Azad Jammu and Kashmir, Pakistan. In this context, 160 houses were carefully selected for the installation of CR-39-based National Radiological Protection Board-type detectors installation. After exposing the CR-39 detectors for a period of 90 d, they were etched in 6 M chemical solution of sodium hydroxide at a temperature of 80°C for a period of 16 h. The detectors were read under an optical microscope and observed track densities were converted into the indoor radon concentration using a calibration factor of 2.7 tracks cm(-2) h(-1) per kBqm(-3). For the current study, observed radon concentrations ranged from 35 to 175 Bqm(-3), whereas the mean annual effective radon doses received by the inhabitants of the area ranged from 0.88 ± 0.12 to 4.41 ± 0.20 mSv with an average value of 2.62 ± 0.12 mSv. These reported values are less than the limits (standards) recommended by the different world organisations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940793     DOI: 10.1093/rpd/ncs198

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  1 in total

1.  The Influence of Internal Wall and Floor Covering Materials and Ventilation Type on Indoor Radon and Thoron Levels in Hospitals of Kermanshah, Iran.

Authors:  Meghdad Pirsaheb; Farid Najafi; Abbas Haghparast; Lida Hemati; Kiomars Sharafi; Nematullah Kurd
Journal:  Iran Red Crescent Med J       Date:  2016-08-07       Impact factor: 0.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.